BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2677985)

  • 1. The place of quinolones in the treatment of respiratory tract infections.
    van der Meer JW
    Pharm Weekbl Sci; 1989 Aug; 11(4):132-3. PubMed ID: 2677985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fluoroquinolones in lower respiratory tract infections.
    Vellend H
    Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the quinolones in antibacterial therapy.
    Van Landuyt HW; Magerman K; Gordts B
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():1-6. PubMed ID: 2286584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP; Jacobs F; Byl B
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new quinolones in the treatment of respiratory tract infections.
    Finch RG
    Drugs; 1995; 49 Suppl 2():144-51. PubMed ID: 8549285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolones in the treatment of bronchopulmonary infections.
    Thys JP
    Rev Infect Dis; 1988; 10 Suppl 1():S212-7. PubMed ID: 3279495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.
    Blasi F; Tarsia P; Cosentini R; Cazzola M; Allegra L
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1165-77. PubMed ID: 12831351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolones in the treatment of lower respiratory tract infections.
    Thys JP; Jacobs F; Motte S
    Rev Infect Dis; 1989; 11 Suppl 5():S1212-9. PubMed ID: 2672250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fluoroquinolones in respiratory tract infections.
    Grossman RF
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():59-62. PubMed ID: 9484874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?
    Momméja-Marin H; Carbon C
    Drugs; 1999 Jun; 57(6):851-3. PubMed ID: 10400400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.
    Chidiac C; Mouton Y
    Infection; 1991; 19 Suppl 7():S365-71. PubMed ID: 1804785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guide to the treatment of lower respiratory tract infections.
    Vogel F
    Drugs; 1995 Jul; 50(1):62-72. PubMed ID: 7588090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolones in the treatment of lower respiratory tract infections in adult patients.
    Carbon C
    Drugs; 1993; 45 Suppl 3():91-7. PubMed ID: 7689458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction.
    Craig WA
    Respir Med; 2001 Jun; 95 Suppl A():S2-4; discussion S26-7. PubMed ID: 11419670
    [No Abstract]   [Full Text] [Related]  

  • 18. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and interventions in lower respiratory tract infections.
    Wijnands GJ
    Am J Med; 1992 Apr; 92(4A):91S-97S. PubMed ID: 1580272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.
    Bayer AS
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1102-10. PubMed ID: 2695331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.